Bank of New York Mellon
IRON icon

Bank of New York Mellon’s Disc Medicine IRON Stock Holding History

Bank of New York Mellon’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Sell
204,727
-241
-0.1% -$16.6K ﹤0.01% 1807
2026
Q1 		$13.1M Buy
204,968
+137,261
+203% +$9.53M ﹤0.01% 1778
2025
Q4 		$5.38M Buy
67,707
+2,907
+4% +$246K ﹤0.01% 2280
2025
Q3 		$4.28M Sell
64,800
-6,702
-9% -$399K ﹤0.01% 2408
2025
Q2 		$3.79M Buy
71,502
+7,999
+13% +$376K ﹤0.01% 2428
2025
Q1 		$3.15M Buy
63,503
+6,242
+11% +$347K ﹤0.01% 2450
2024
Q4 		$3.63M Buy
57,261
+4,356
+8% +$252K ﹤0.01% 2457
2024
Q3 		$2.6M Buy
52,905
+1,855
+4% +$87.1K ﹤0.01% 2623
2024
Q2 		$2.3M Buy
51,050
+24,094
+89% +$819K ﹤0.01% 2723
2024
Q1 		$1.68M Sell
26,956
-3,548
-12% -$230K ﹤0.01% 2865
2023
Q4 		$1.76M Sell
30,504
-46
-0.2% -$2.35K ﹤0.01% 2897
2023
Q3 		$1.44M Buy
30,550
+5,567
+22% +$278K ﹤0.01% 2981
2023
Q2 		$1.11M Buy
+24,983
New +$886K ﹤0.01% 3137
2022
Q4 		– Sell
-367
Closed -$18K – 4510
2022
Q3 		$18K Hold
367
– – ﹤0.01% 4462
2022
Q2 		$19K Sell
367
-1,936
-84% -$85.6K ﹤0.01% 4500
2022
Q1 		$96K Sell
2,303
-55
-2% -$2.88K ﹤0.01% 4413
2021
Q4 		$205K Sell
2,358
-77
-3% -$7.55K ﹤0.01% 4265
2021
Q3 		$295K Buy
2,435
+350
+17% +$47.8K ﹤0.01% 4044
2021
Q2 		$404K Buy
2,085
+1,697
+437% +$558K ﹤0.01% 3865
2021
Q1 		$158K Buy
+388
New +$173K ﹤0.01% 4104

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Bank of New York Mellon's IRON Position: Q2 2026 in Review

Bank of New York Mellon reduced its Disc Medicine (IRON) stake by 0.12% in Q2 2026, selling an estimated $16.6K and leaving 204,727 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Bank of New York Mellon first reported a position in IRON in Q1 2021 and has held it in 20 quarters since. 89 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Bank of New York Mellon held 204,727 shares of Disc Medicine worth $15M as of Q2 2026.
  • Bank of New York Mellon sold 241 Disc Medicine shares in Q2 2026, an estimated $16.6K.
  • Disc Medicine made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1807 holding.
  • Bank of New York Mellon first reported a position in Disc Medicine in Q1 2021 and has held it in 20 quarters since.
  • 89 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.